gingerol, provided the basis for this study in the presence of metabolic activation to assess the effective dose level.
Human lymphocyte culture of two healthy donors was carried out. [3] Later, metaphases were examined for different types of aberrations. For sister chromatid exchange analysis, bromodeoxyuridine (10 µg/ml) was added at the beginning of the culture. [4] Cell cycle kinetics was studied by the BrdU-Harlequin technique using the replication index (RI) calculated by the standard formula. [5] The Student 't'-test was used for statistical analysis using 'Statistica' software (StatSoft, Inc.).
In this study, cisplatin was tested in vitro in human lymphocytes for its toxicity potential using chromosomal aberrations, sister chromatid exchanges, and cell cycle kinetics as parameters, and it was found to be genotoxic only when activated metabolically in the presence of S9 mix [ Tables 1 and 2 ]. This means that cisplatin can be genotoxic
Protective Action of Flavonoids Genistein and Gingerol against Cisplatin Toxicity In Vitro
Sir, Cisplatin is a platinum-based chemotherapy drug used for treating cancers and has proved to be toxic in earlier studies. Cisplatin has a number of side effects that can limit its usage. Many agents have been shown to ameliorate cisplatin toxicity. [1] Genistein is an antioxidant isoflavone found in many plants as well as animal cells, soybeans, and soy products being a major source. Gingerol is the active constituent of fresh ginger and a proven antioxidant. Genistein and gingerol have been reported for their antigenotoxic and antimutagenic potential in cultured human lymphocytes. [2] The earlier reported toxicity of cisplatin, the antimutagenic action of genistein and Letter to the Editor Letter to the Editor diet could protect patients undergoing chemotherapy as shown by studies where antioxidants were combined with chemotherapeutic drugs that increased growth-inhibition of chemotherapeutic agents on cancers. [8] Cancer cells and normal cells are different, which helps antioxidant complementary therapy protect the normal tissues from damage due to chemotherapeutic agents without compromising therapeutic effectiveness. [8] It is concluded that the toxicity of cisplatin could be significantly reduced by combining cisplatin and antioxidants during chemotherapy to minimize the risk of secondary tumors. Anticancer drugs could be developed further commercially from antioxidants like genistein and gingerol. 
